Camlin Fine Sciences Ltd Annually Results

Gross Sales

1,613.06

1,681.56

1,412.09

1,187.1

1,049.15

Excise Duty

0

0

0

0

0

Net Sales

1,613.06

1,681.56

1,412.09

1,187.1

1,049.15

Other Operating Income

0

0

0

0

0

Other Income

15.56

5.8

33.03

4.98

3.43

Total Income

1,628.62

1,687.36

1,445.12

1,192.09

1,052.58

Total Expenditure

1,588.95

1,485.97

1,259.41

1,005.17

918.44

PBIDT

39.67

201.39

185.71

186.92

134.13

Interest

60.3

58.5

35.77

37.53

43.13

PBDT

-20.64

142.89

149.94

149.39

91

Depreciation

78.61

62.51

55.96

44.29

32.8

Minority Interest Before NP

0

0

0

0

0

Tax

24.87

28.68

32.07

27.36

24.89

Deferred Tax

-19.24

11.89

1.53

12.38

3.48

Reported Profit After Tax

-104.88

39.81

60.37

65.36

29.83

Minority Interest After NP

-12.12

-12.3

-0.31

14.39

-0.49

Net Profit after Minority Interest

-92.75

52.11

60.68

50.96

30.32

Extra-ordinary Items

-37.32

-4.79

0

0

0

Adjusted Profit After Extra-ordinary item

-55.43

56.9

60.68

50.96

30.32

EPS (Unit Curr.)

-5.58

3.45

4.65

4.13

2.5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.75

15.71

15.7

12.75

12.13

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

2.45

11.97

13.15

15.74

12.78

PBDTM(%)

-1.27

8.49

10.61

12.58

8.67

PATM(%)

-6.5

2.36

4.27

5.5

2.84